Serial #98354467
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

Serial #98354467 Trademark

Serial Number: 98354467

Serial #98354467 is a trademark filed by Neurocrine Biosciences, Inc. on January 12, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Neurocrine Biosciences, Inc. (237 trademarks)

6027 Edgewood Bend Court
San Diego, CA 92130

Entity Type: 03

Trademark Details

Filing Date

January 12, 2024

Registration Date

Not Registered

Published for Opposition

April 1, 2025

Goods & Services

Providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders; on-line information services, namely, providing medical information to patients, medical professionals, and insurance companies in the field of congenital adrenal hyperplasia and other endocrine diseases and disorders

pharmaceutical preparations for the diagnosis, prevention and treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia

providing medical research information in the field of pharmaceuticals and clinical trials focusing on congenital adrenal hyperplasia and other endocrine diseases and disorders; Conducting clinical trials for pharmaceutical preparations for the treatment of congenital adrenal hyperplasia and other endocrine diseases and disorders; conducting post-authorization research for the marketing of pharmaceutical preparations and evaluating epidemiological results

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 29, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 29, 2025 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 27, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 1, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 1, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 26, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 9, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 9, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 9, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 9, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 9, 2025 CNEA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Aug 27, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Aug 27, 2024 XELR
NOTIFICATION OF PRIORITY ACTION E-MAILED
Aug 15, 2024 GPRN
PRIORITY ACTION E-MAILED
Aug 15, 2024 GPRA
PRIORITY ACTION WRITTEN
Aug 15, 2024 CPRA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jul 31, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 31, 2024 XELR
NOTIFICATION OF PRIORITY ACTION E-MAILED
May 30, 2024 GPRN
PRIORITY ACTION E-MAILED
May 30, 2024 GPRA
PRIORITY ACTION WRITTEN
May 30, 2024 CPRA
ASSIGNED TO EXAMINER
May 22, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 5, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 5, 2024 NWOS
NEW APPLICATION ENTERED
Jan 12, 2024 NWAP